#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal adenocarcinoma stage III Mucous membrane pemphigoid Microscopic polyangiitis Krabbe's disease Renal cell carcinoma Desmoid tumour Familial dilated cardiomyopathy Pulmonary alveolar haemorrhage T-cell type acute leukaemia Necrotising enterocolitis neonatal Diffuse large B-cell lymphoma Severe myoclonic epilepsy of infancy Choroidal dystrophy Progressive supranuclear palsy Mitochondrial DNA depletion More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV – Treatment Proteus syndrome – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Antisynthetase syndrome – Life with Disease Leiomyosarcoma – Diagnostics Lysosomal storage disorder – Trials in Disease Pulmonary fibrosis – Treatment Pemphigus – Basic Information Wolfram syndrome Brain stem glioma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pramlintide Acetate Eo2317 Etravirine Lenvatinib Ribonucleic Acid K30 E2814 Art0380 Mesilate Soft Paraffin And Fat Products Rifapentine Lorazepam Tofogliflozin Mps-215 Relacorilant Dexamethasone Acetate Ph. Eur. Palmidrol Hexaminolevulinate Palivizumab Egl-001 Azetukalner Tenofovir Alafenamide More therapies…

    Learn about Your Condition

    Glioblastoma multiforme Pleural mesothelioma Oral neoplasm Ebola disease Chronic spontaneous urticaria Pathogen resistance Fabry's disease Penile cancer Stargardt's disease Hyperchylomicronaemia Mantle cell lymphoma stage IV Hodgkin's disease refractory Red blood cell abnormality Lipid metabolism disorder Partial seizures More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Muascn Zopnljff Kgejs 2rv Dcmqdzowh 4ltpg Hmupvsk

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Relacorilant
    • Paclitaxel Albumin-Bound
    Belgium France Hungary Italy Poland Spain

  • Study on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Secukinumab
    Austria Belgium Bulgaria Croatia Czechia Greece +8

  • Study on TIN816 for Preventing Acute Kidney Injury in Adults Undergoing Cardiac Surgery

    Not recruiting

    2 1
    Investigated Drugs:
    • Tin816
    Belgium Czechia Estonia France Germany Hungary +1

  • Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

    Not recruiting

    4 1
    Investigated Diseases:
    • Idiopathic inflammatory myopathy
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Belgium Bulgaria Cyprus Czechia Denmark +13

  • Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Epcoritamab
    • Gemcitabine
    • Lenalidomide
    Belgium Bulgaria Croatia Czechia France Greece +5

  • Study on Aflibercept for Adults with Diabetic Macular Edema or Wet Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    Czechia Hungary Slovakia

  • Study on the Safety and Efficacy of MK-0616 for Adults with High Cholesterol

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Enlicitide Chloride
    Czechia Finland France Germany Hungary Italy +3

  • Study on the Effectiveness and Safety of Lazertinib and Gefitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung adenocarcinoma stage III
    • Lung adenocarcinoma stage IV
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Gefitinib
    • Lazertinib
    Greece Hungary

  • Study of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Remibrutinib
    Bulgaria Czechia Denmark France Germany Hungary +4

  • Study on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Urticaria cholinergic
    • Cold urticaria
    • Urticaria chronic
    Investigated Drugs:
    • Remibrutinib
    France Germany Hungary Italy The Netherlands Poland +4
Previous Page
1 … 29 30 31 32 33 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!